ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

NCCS Networker Volume 6 Issue 1, Winter 1992

January 13, 1992

Congress Passes NIH Reauthorization.

December 15, 2006

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

September 9, 2005

Chart of FY 1991 Budget For NCI By Mechanism

February 2, 1990

In Brief: NCI to Extend Frederick contract To SAIC; Klausner, Gallin, Gail Elected to IOM

October 24, 1996